Frontotemporal atrophy associated with paranoid delusions in women with Alzheimer's disease

International Psychogeriatrics

Volumn 24, Issue 1, 2012, Pages 99-107

  Whitehead, D ^a   Tunnard, C ^a   Hurt, C ^a   Wahlund, L O ^b   Mecocci, P ^c   Tsolaki, M ^d   Vellas, B ^e   Spenger, C ^b   Kloszewska I ^f   Soininen, H ^g   Cromb, D ^a   Lovestone, S ^a   Simmons, A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF PERUGIA   (Italy)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

^f MEDICAL UNIVERSITY OF LODZ   (Poland)

^g KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; imaging; psychosis; sex differences

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOMATION; COGNITIVE DEFECT; CONTROLLED STUDY; DELUSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORBITAL CORTEX; PARANOIA; PARTICIPANT OBSERVATION; SUPERIOR TEMPORAL GYRUS;

AGED; ALZHEIMER DISEASE; ATROPHY; DELUSIONS; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; PARANOID DISORDERS; SEX FACTORS; TEMPORAL LOBE;

EID: 82055166108     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610211000974     Document Type: Article

References (30)

1. Binetti, G. et al. (1995). Delusions and dementia: clinical and CT correlates. Acta Neurologica Scandinavica, 91, 271-275.
2. Blackwood, N. J., Howard, R. J., Bentall, R. P. and Murray, R. M. (2001). Cognitive neuropsychiatric models of persecutory delusions. American Journal of Psychiatry, 158, 527-539. (Pubitemid 32289815)
3. Bruen, P. D., McGeown, W. J., Shanks, M. F. and Venneri, A. (2008). Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain, 131, 2455-2463.
4. Burns, A. (1996). The Institute of Psychiatry Alzheimer's disease cohort 1986-1992. 1. Clinical observations. International Journal of Geriatric Psychiatry, 11, 309-320.
5. Cummings, J. L. (1997). The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology, 48, S10-S16. (Pubitemid 27232698)
6. Drury V. M., Robinson E. J., Birchwood M. (1998) "Theory of mind" skills during an acute episode of psychosis and following recovery. Psychological Medicine, 28, 1101-1112. (Pubitemid 28458466)
7. Fischer C., Bozanovic, R., Atkins, J. H. and Rourke, S. B. (2006). Treatment of delusions in Alzheimer's disease: response to pharmacotherapy. Dementia and Geriatric Cognitive Disorders, 22, 260-266. (Pubitemid 44310523)
8. Fischl, B. and Dale, A. M. (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences of the United States of America, 97, 11050-11055.
9. Fischl, B. et al. (2004). Sequence-independent segmentation of magnetic resonance images. Neuroimage, 23, S69-S84. (Pubitemid 39429376)
10. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). "Mini-mental state": practical method for grading cognitive state of patients for clinician. Journal of Psychiatric Research, 12, 189-198.
11. Fukuhara, R. et al. (2001). Alteration of rCBF in Alzheimer's disease patients with delusions of theft. Neuroreport, 12, 2473-2476. (Pubitemid 32682205)
12. Geroldi, C., Bresciani, L., Zanetti, O. and Frisoni, G. B. (2002). Regional brain atrophy in patients with mild Alzheimer's disease and delusions. International Psychogeriatrics, 14, 365-378. (Pubitemid 36331603)
13. Kloszewska, I. (1998). Incidence and relationship between behavioural and psychological symptoms in Alzheimer's disease. International Journal of Geriatric Psychiatry, 13, 785-792. (Pubitemid 28542710)
14. Lee, D. Y. et al. (2006). White matter changes associated with psychotic symptoms in Alzheimer's disease patients. Journal of Neuropsychiatry and Clinical Neurosciences, 18, 191-198.
15. Lovestone, S., Francis, P. and Strandgaard, K. (2007). Biomarkers for disease modification trials: the innovative medicines initiative and AddNeuroMed. Journal of Nutrition Health and Aging, 11, 359-361. (Pubitemid 47121941)
16. Magni, E., Binetti, G., Bianchetti, A. and Trabucchi, M. (1996). Risk of mortality and institutionalization in demented patients with delusions. Journal of Geriatric Psychiatry and Neurology, 9, 123-126. (Pubitemid 26319348)
17. Mega, M. S., Lee, L., Dinov, I. D., Mishkin, F., Toga, A. W. and Cummings, J. L. (2000). Cerebral correlates of psychotic symptoms in Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry, 69, 167-171. (Pubitemid 30466019)
18. Mentis, M. J. et al. (1995). Abnormal brain glucose-metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease. Biological Psychiatry, 38, 438-449.
19. Moran, E. K., Becker, J. A., Satlin, A., Lyoo, I. K., Fischman, A. J. and Johnson, K. A. (2008). Psychosis of Alzheimer's disease: gender differences in regional perfusion. Neurobiology of Aging, 29, 1218-1225. (Pubitemid 351822416)
20. Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412-2414. (Pubitemid 23346995)
21. Nakano, S., Yamashita, F., Matsuda, H., Kodama, C. and Yamada, T. (2006). Relationship between delusions and regional cerebral blood flow in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 21, 16-21. (Pubitemid 41797966)
22. Phillips, M. L., Senior, C. and David, A. S. (2000). Perception of threat in schizophrenics with persecutory delusions: an investigation using visual scan paths. Psychological Medicine, 30, 157-167. (Pubitemid 30099128)
23. Reeves, S., Brown, R., Howard, R. and Grasby, P. (2009). Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease. Neurology, 72, 528-534.
24. Reisberg, B., Ferris, S. H., Deleon, M. J. and Crook, T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139, 1136-1139. (Pubitemid 12051593)
25. Rosen, W. G., Mohs, R. C. and Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141, 1356-1364.
26. Schneider, L. S., Dagerman, K. S. and Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 1934-1943. (Pubitemid 41464695)
27. Simmons, A. et al. for the AddNeuroMed Consortium (2011). The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. International Journal of Geriatric Psychiatry, 26, 75-82.
28. Sultzer,D. L., Brown, C. V.,Mandelkern, M. A., Mahler, M. E., Chen, S. T. and Cummings, J. L. (2003). Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. American Journal of Psychiatry, 160, 341-349. (Pubitemid 41110461)
29. Whittaker, J. F., Deakin, J. F. W. and Tomenson, B. (2001). Face processing in schizophrenia: defining the deficit. Psychological Medicine, 31, 499-507. (Pubitemid 32294048)
30. Young, H. F. and Bentall, R. P. (1997). Probabilistic reasoning in deluded, depressed and normal subjects: effects of task difficulty and meaningful versus non-meaningful material. Psychological Medicine, 27, 455-465. (Pubitemid 27139977)